CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | Gendel Mitchell Global General Counsel | Purchase | +2,500 | $4.43 | $11K | 124,883 |
| 2026-08-04 | Merton Carl A Chief Financial Officer | Purchase | +10,000 | $4.62 | $46K | 139,753 |
| 2026-08-03 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | +2,500 | $4.78 | $12K | 141,285 |
| 2025-07-31 | Gendel Mitchell Global General Counsel | Purchase | +6,000 | $0.58 | $3K | 698,287 |
| 2025-07-30 | SIMON IRWIN D President and CEO | Purchase | +165,000 | $0.61 | $100K | 3,941,633 |
| 2025-07-30 | Merton Carl A Chief Financial Officer | Purchase | +33,500 | $0.60 | $20K | 798,069 |
| 2024-11-15 | Merton Carl A Chief Financial Officer | Purchase | +26,000 | $1.36 | $35K | 26,000 |
| 2024-01-17 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | +10,000 | $2.05 | $21K | 293,269 |
| 2024-01-16 | Gendel Mitchell Global General Counsel | Purchase | +7,200 | $1.98 | $14K | 195,796 |
| 2024-01-12 | Gendel Mitchell Global General Counsel | Purchase | +5,400 | $1.87 | $10K | 188,596 |
| 2024-01-12 | SIMON IRWIN D President and CEO | Purchase | +53,700 | $1.88 | $101K | 2,033,058 |
| 2024-01-12 | Merton Carl A Chief Financial Officer | Purchase | +20,000 | $1.87 | $37K | 20,000 |
Page 1 of 1 · 12 trades